Funded Tech Companies
Stargazer Pharmaceuticals
Wondering who invested in Stargazer Pharmaceuticals? Novo Ventures, venBio and Canaan Partners joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Stargazer Pharmaceuticals
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
200 Clarendon St. 45th Floor Mailbox 30
Boston, MA 02215
USA
Boston, MA 02215
USA
Phone
Email Address
Not Recorded
Company Background Information
Overview
Stargazer Pharmaceuticals, Inc., is a Boston-based biopharmaceutical drug development company launched in 2018 with a focus on rare diseases of the eye, and an initial focus on Stargardt Disease.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/10/2020
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gary Sternberg
Chief Marketing Officer
Houman Hemmati
Chief Operating Officer
Silvia Ragno
Company Investors
- Novo Ventures
- venBio
- Canaan Partners
- Pontifax AgTech
- Retinal Degeneration
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs